Panagiota-Efstathia Nikolaou, PhD, National and Kapodistrian University of Athens, Athens, Greece, comments on the need to develop better therapies in patients with AL amyloidosis with cardiac involvement, highlighting the potential of targeting endoplasmic reticulum (ER) to alleviate cardiac damage in those patients. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.